Healthcare - Quarterly Revenue Analysis

Last updated 2025-04-10 20:31:08 (EDT)

Quarterly Revenue Trend Analysis

Overall Quarterly Revenue Growth Trend of Healthcare Sector Companies.

Trend Chart of Adjusted Quarterly Revenue vs. Stock Price Trend Chart for Healthcare Sector ETF (XLV)

FindBillion.com

Seasonally Adjusted Quarterly Revenue Growth Rate


QoQ Growth Rate of Revenue	1%
YoY Growth Rate of Revenue	8.8%

Correlation Analysis between Quarterly Revenue and Stock Price

Determine the correlation between the stock price of the Healthcare Sector ETF (XLV) and the seasonally adjusted overall quarterly revenue of Healthcare sector companies. If there is a moderate to high correlation, the overall seasonally adjusted quarterly revenue can be used to estimate whether the stock price is reasonable.

Scatter Plot of Seasonally Adjusted Quarterly Revenue vs. Stock Price for Healthcare Sector

Seasonally Adjusted Quarterly Revenue and stock price of Healthcare Sector show a High Correlation. The higher the correlation, the greater the reference value.

The Coefficient of Determination
between Seasonally Adjusted Quarterly Revenue and Stock Price

High Correlation 0.93

FindBillion.com

Related Stocks

Related Healthcare sector stocks, along with their quarterly revenue growth rates (QoQ and YoY).

Ticker	Name	QoQ Growth Rate of Seasonally Adjusted Quarterly Revenue	YoY Growth Rate of Seasonally Adjusted Quarterly Revenue
BBIO	BridgeBio Pharma, Inc.	418.3%	237.1%
ROIV	Roivant Sciences Ltd.	129.8%	-75.7%
ASND	Ascendis Pharma A/S	109.1%	26.3%
ARGX	argenx SE	78.6%	330.2%
VRNA	Verona Pharma plc	77.8%	3799.2%
TGTX	TG Therapeutics, Inc.	67.9%	146%
MDGL	Madrigal Pharmaceuticals, Inc.	56.1%	13318.2%
PODD	Insulet Corporation	52.5%	17.2%
ONC	BeiGene, Ltd.	50.9%	77.8%
BPMC	Blueprint Medicines Corporation	37.6%	103.4%
AXSM	Axsome Therapeutics, Inc.	26.3%	66%
NBIX	Neurocrine Biosciences, Inc.	18%	21.8%
NVO	Novo Nordisk A/S	15.1%	30.1%
DHR	Danaher Corporation	13.1%	142.8%
EXEL	Exelixis, Inc.	12.7%	18.2%
MASI	Masimo Corporation	12.1%	9.4%
NTRA	Natera, Inc.	9.6%	53%
DOCS	Doximity, Inc.	9.4%	24.6%
LLY	Eli Lilly and Company	9.1%	44.7%
ISRG	Intuitive Surgical, Inc.	8.9%	25.2%
RGEN	Repligen Corporation	8.8%	7.6%
HLN	Haleon plc	7.3%	-0.3%
DGX	Quest Diagnostics Incorporated	7%	14.6%
OPCH	Option Care Health, Inc.	6.5%	19.7%
GKOS	Glaukos Corporation	5.9%	28.1%
RDY	Dr. Reddy's Laboratories Limited	5.5%	15.9%
AZN	AstraZeneca PLC	5.5%	23.8%
BSX	Boston Scientific Corporation	5.2%	22.4%
DVA	DaVita Inc.	5%	4.7%
ENSG	The Ensign Group, Inc.	4.8%	15.5%
SYK	Stryker Corporation	4.3%	10.7%
CI	Cigna Corporation	4.3%	28.7%
FMS	Fresenius Medical Care AG & Co. KGaA	4.3%	1.9%
DXCM	DexCom, Inc.	4.2%	7.6%
VEEV	Veeva Systems Inc.	3.9%	14.3%
TLX	Telix Pharmaceuticals Limited	3.9%	55.7%
UTHR	United Therapeutics Corporation	3.9%	19.7%
RPRX	Royalty Pharma plc	3.8%	-0.3%
STVN	Stevanato Group S.p.A.	3.8%	5.8%
TAK	Takeda Pharmaceutical Company Limited	3.7%	12.7%
CHE	Chemed Corporation	3.5%	9.2%
MMSI	Merit Medical Systems, Inc.	3.1%	9.9%
AMGN	Amgen Inc.	3.1%	10.9%
GSK	GSK plc	3%	0.8%
HUM	Humana Inc.	3%	10.4%
ICLR	ICON Public Limited Company	2.6%	-1.2%
MOH	Molina Healthcare, Inc.	2.6%	16%
GEHC	GE HealthCare Technologies Inc.	2.5%	2.2%
ITCI	Intra-Cellular Therapies, Inc.	2.5%	51.5%
PEN	Penumbra, Inc.	2.3%	10.8%
ABBV	AbbVie Inc.	2.2%	5.6%
LNTH	Lantheus Holdings, Inc.	2.1%	10.5%
ZBH	Zimmer Biomet Holdings, Inc.	2%	4.3%
CAH	Cardinal Health, Inc.	2%	-3.8%
ALNY	Alnylam Pharmaceuticals, Inc.	1.9%	34.9%
EHC	Encompass Health Corporation	1.9%	12.7%
ELV	Elevance Health Inc.	1.7%	6.6%
UHS	Universal Health Services, Inc.	1.7%	11.1%
STE	STERIS plc	1.6%	-1.8%
TECH	Bio-Techne Corporation	1.6%	9%
UNH	UnitedHealth Group Incorporated	1.6%	8.1%
COR	Cencora, Inc.	1.4%	12.8%
MTD	Mettler-Toledo International Inc.	1.2%	11.8%
HCA	HCA Healthcare, Inc.	1.2%	5.7%
MEDP	Medpace Holdings, Inc.	1.1%	7.7%
ALGN	Align Technology, Inc.	0.9%	4%
JAZZ	Jazz Pharmaceuticals plc	0.9%	7.5%
SNN	Smith & Nephew plc	0.9%	14.1%
BDX	Becton, Dickinson and Company	0.8%	9.8%
A	Agilent Technologies, Inc.	0.8%	1.4%
IDXX	IDEXX Laboratories, Inc.	0.7%	5.8%
MCK	McKesson Corporation	0.7%	17.8%
BMRN	BioMarin Pharmaceutical Inc.	0.7%	15.6%
INSM	Insmed Incorporated	0.6%	24.8%
ABT	Abbott Laboratories	0.6%	7.2%
BIIB	Biogen Inc.	0.4%	2.9%
TEM	Tempus AI, Inc.	0.1%	35.8%
LH	Laboratory Corporation of America Holdings	-	9.8%
WST	West Pharmaceutical Services, Inc.	-	2.3%
BMY	Bristol-Myers Squibb Company	-	7.5%
CNC	Centene Corporation	-0.1%	3.4%
EW	Edwards Lifesciences Corporation	-0.2%	-9.7%
CVS	CVS Health Corporation	-0.3%	4.2%
CORT	Corcept Therapeutics Incorporated	-0.5%	34.3%
HQY	HealthEquity, Inc.	-0.5%	18.8%
BAX	Baxter International Inc.	-0.8%	-29.1%
NVS	Novartis AG	-1%	15.1%
ALC	Alcon Inc.	-1%	0.9%
ILMN	Illumina, Inc.	-1%	-1.6%
HOLX	Hologic, Inc.	-1.2%	0.9%
VRTX	Vertex Pharmaceuticals Incorporated	-1.3%	15.7%
SOLV	Solventum Corporation	-1.3%	-1%
BRKR	Bruker Corporation	-1.4%	14.6%
TMO	Thermo Fisher Scientific Inc.	-1.5%	4.7%
GILD	Gilead Sciences, Inc.	-1.6%	6.4%
MDT	Medtronic plc	-1.7%	2.5%
CRL	Charles River Laboratories International, Inc.	-1.8%	-1.1%
RMD	ResMed Inc.	-1.9%	10.3%
ATR	AptarGroup, Inc.	-2.4%	1.1%
ALKS	Alkermes plc	-2.4%	13.9%
COO	The Cooper Companies, Inc.	-2.6%	3.6%
EXAS	Exact Sciences Corporation	-2.8%	10.3%
WAT	Waters Corporation	-2.9%	6.5%
TFX	Teleflex Incorporated	-2.9%	2.8%
PFE	Pfizer Inc.	-3%	24.7%
QGEN	Qiagen N.V.	-3.1%	2.4%
JNJ	Johnson & Johnson	-3.2%	5.3%
WBA	Walgreens Boots Alliance, Inc.	-3.3%	4.1%
SRPT	Sarepta Therapeutics, Inc.	-3.8%	65.9%
ELAN	Elanco Animal Health Incorporated	-3.8%	-1.4%
HSIC	Henry Schein, Inc.	-4.1%	5.8%
GH	Guardant Health, Inc.	-4.2%	30.2%
MRK	Merck & Co., Inc.	-4.5%	6.8%
REGN	Regeneron Pharmaceuticals, Inc.	-4.5%	10.3%
ZTS	Zoetis Inc.	-4.6%	4.7%
THC	Tenet Healthcare Corporation	-4.8%	-5.7%
GMED	Globus Medical, Inc.	-5%	6.6%
RVTY	Revvity, Inc.	-5.7%	4.8%
INCY	Incyte Corporation	-5.7%	16.3%
IQV	IQVIA Holdings Inc.	-6.3%	1.3%
PHG	Koninklijke Philips N.V.	-6.9%	-0.4%
BIO	Bio-Rad Laboratories, Inc.	-7.2%	-2%
VTRS	Viatris Inc.	-8.3%	-8.1%
TEVA	Teva Pharmaceutical Industries Limited	-9.2%	-5.1%
HALO	Halozyme Therapeutics, Inc.	-25.9%	29.5%
GMAB	Genmab A/S	-29.2%	37.7%
KRYS	Krystal Biotech, Inc.	-30.3%	116.3%
BNTX	BioNTech SE	-38.1%	-19.5%
SNY	Sanofi	-46.7%	-66.7%
MRNA	Moderna, Inc.	-64.6%	-65.7%
GRFS	Grifols, S.A.	-100%	-100%
NUVL	Nuvalent, Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-100%
SMMT	Summit Therapeutics Inc.	-	-

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.